Dioxybenzone

Drug profile

Key facts

Dioxybenzone is a drug catalogued in DrugCentral. Recorded indications include Chloasma, Discoloration of skin and Facial Hyperpigmentation.

• Indications: Chloasma, Discoloration of skin and Facial Hyperpigmentation.
• Molecular formula: C14H12O4; molecular weight 244.25 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (3)

• Chloasma
• Discoloration of skin
• Facial Hyperpigmentation

Regulatory approvals (1)

Date	Agency	Marketed as	Applicant	Orphan
—	FDA	—	—

Chemical structure

Full physicochemical, ADMET and 3D-structure analysis of Dioxybenzone is on its molecule page.

• Molecular formula: C₁₄H₁₂O₄
• Molecular weight: 244.25 g/mol
• CAS number: 131-53-3
• InChIKey: MEZZCSHVIGVWFI-UHFFFAOYSA-N
• PubChem CID: 8569

COC1=CC(O)=C(C=C1)C(=O)C1=C(O)C=CC=C1

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Dioxybenzone used for?

DrugCentral lists the following indications for Dioxybenzone: Chloasma, Discoloration of skin and Facial Hyperpigmentation.

What is the chemical formula of Dioxybenzone?

Dioxybenzone has the molecular formula C14H12O4 and a molecular weight of 244.25 g/mol.

Sources

• DrugCentral drug card 3159 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
• ChEMBL CHEMBL1326877 — compound record and bioactivity
• PubChem CID 8569 — chemical identifiers
• DrugBank DB11221 — drug record
• FDA UNII B762XZ551X — substance identity
• DailyMed: FDA labels for Dioxybenzone — current prescribing information (label search)

How this page is built: methodology · editorial policy & corrections.